The field of percutaneous coronary intervention (PCI) remains extremely active, with major advances involving revascularisation strategies and techniques, adjuvant antithrombotic therapy (with a particular emphasis this year on the optimal duration of antiplatelet therapy after drug-eluting stent (DES) stenting), concerns regarding the importance and risks of bleeding and methods to decrease those risks and a strong focus on the study of newer generation DES and bioresorbable devices with lingering concerns regarding the safety of the latter.
Norihiro Kogame, Patrícia O. Guimarães, Rodrigo Modolo, Fernando De Martino, Joao Tinoco, Expedito E. Ribeiro, Hideyuki Kawashima, Masafumi Ono, Hironori Hara, Rutao Wang, Rafael Cavalcante, Bruno Moulin, Breno de Alencar Araripe Falcão, Rogério Sarmento Leite, Fernanda Barbosa de Almeida Sampaio, Gustavo R. Morais, George César Ximenes Meireles, Carlos M. Campos, Yoshinobu Onuma, Patrick W. Serruys, Pedro A. Lemos
Jan‐Peter van Kuijk, Willem‐Jan Flu, Olaf Schouten, Sanne E. Hoeks, Lisanne Schenkeveld, Peter P.T. de Jaegere, Jeroen J. Bax, Ron T. van Domburg, Patrick W. Serruys, Don Poldermans
Patrick W. Serruys, Kuniaki Takahashi, Norihiro Kogame, Ply Chichareon, Rodrigo Modolo, Chun Chin Chang, Mariusz Tomaniak, Hidenori Komiyama, Christian W. Hamm, Philippe Gabríel Steg, H P Stoll, Yoshinobu Onuma, Marco Valgimigli, Stephan Windecker, Pascal Vranckx
Discussion(0)
No comments yet. Be the first to comment.